Form 4: Cognition Therapeutics Director Jack Khattar Granted 34,000 Restricted Stock Units

Cognition Therapeutics Inc. Director Jack A. Khattar was granted 34,000 restricted stock units (RSUs) on June 18, 2025, increasing his beneficial ownership to 48,500 shares.

Summary

• Jack A. Khattar, a Director of Cognition Therapeutics Inc. (CGTX), was granted 34,000 shares of Common Stock in the form of Restricted Stock Units (RSUs).
• The transaction occurred on June 18, 2025, with a price of $0.00 per share, indicating a grant rather than a purchase.
• Following this transaction, Mr. Khattar's beneficial ownership of Common Stock increased to 48,500 shares.
• Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
• The RSUs are scheduled to vest in full on the earlier of June 18, 2026, or the date of the Issuer's next annual meeting of stockholders, contingent on Mr. Khattar's continuous service as a director.

Sentiment

Score: 7

Explanation: The grant of RSUs to a director is generally a positive sign of alignment between management and shareholders, indicating commitment and incentivizing long-term performance. It's a routine compensation event.

Positives

• The grant of Restricted Stock Units (RSUs) to Director Jack A. Khattar aligns his interests with those of shareholders, as the value of the RSUs is tied to the company's stock performance.
• The vesting schedule encourages long-term commitment and continuous service from a key board member.

Future Outlook

The vesting schedule for the granted Restricted Stock Units (RSUs) extends to June 18, 2026, or the date of the next annual meeting, indicating a future commitment period for the director's service.

Industry Context

This transaction is a routine disclosure of director equity compensation, common across publicly traded companies to align management and board interests with shareholder value. It reflects standard corporate governance practices for incentivizing long-term commitment.

Related Party Transactions

• Director Jack A. Khattar, a related party, was granted 34,000 Restricted Stock Units by Cognition Therapeutics Inc. as part of his compensation.

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's interests with shareholders, potentially leading to better long-term performance.

Next Steps

• Continued service of Jack A. Khattar as a director of Cognition Therapeutics Inc.
• Vesting of the 34,000 Restricted Stock Units on the earlier of June 18, 2026, or the date of the Issuer's next annual meeting of stockholders.

Key Dates

Keywords

Cognition Therapeutics, CGTX, SEC Form 4, Restricted Stock Units, RSU, Insider Transaction, Director Compensation, Equity Grant, Stock Ownership